Always consult with a licensed healthcare professional for advice about any medical concerns.
Obesity: Jastreboff et al., 2023 (NEJM) Jastreboff, Kaplan, Fras, and colleagues reported a phase 2, double-blind, randomized, placebo-controlled trial in the New England Journal of Medicine in 2023 [4]
Some individuals dont respond well to semaglutide due to genetic, metabolic, or lifestyle factors
Our goal is to guide you through every step with clarity, education, and ongoing support, ensuring that your treatment feels safe, structured, and entirely personalized to your metabolic needs
Blue Cross Blue Shield (BCBS) may cover Wegovy, but coverage varies significantly by plan, employer, and state
Naturopath focus combing medications if needed using positive lifestyle to limit them